The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice
Article in Molecular Metabolism (August 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Molecular Metabolism (August 2024)
Article in Peptides (July 2024)
Article in Cardiovascular Diabetology (July 2024)